Anthony Alberg to Carcinoma, Basal Cell
This is a "connection" page, showing publications Anthony Alberg has written about Carcinoma, Basal Cell.
Connection Strength
2.510
-
Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review. Arch Dermatol Res. 2017 May; 309(4):243-251.
Score: 0.565
-
Keratinocyte Carcinoma as a Marker of a High Cancer-Risk Phenotype. Adv Cancer Res. 2016; 130:257-91.
Score: 0.525
-
A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer. Cancer Epidemiol. 2012 Oct; 36(5):e288-93.
Score: 0.406
-
A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer. J Invest Dermatol. 2012 May; 132(5):1354-62.
Score: 0.398
-
Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst. 2008 Sep 03; 100(17):1215-22.
Score: 0.313
-
Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship. Anticancer Res. 2019 Sep; 39(9):5083-5087.
Score: 0.168
-
Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7):1686-95.
Score: 0.089
-
Serological precursors of cancer: malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, beta- carotene, lycopene, alpha-tocopherol, and selenium. Cancer Epidemiol Biomarkers Prev. 1995 Dec; 4(8):837-42.
Score: 0.032
-
XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev. 2004 Aug; 13(8):1271-5.
Score: 0.015